Puma Biotechnology Inc
NASDAQ: PBYI
$3.10
+$0.20 (+6.7%)
Real Time Data Delayed 15 Min.
PBYI Articles
24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in the June quarter. We have added some color.
Published:
Last Updated:
March 29, 2016: Here are four stocks trading with relatively heavy volume among 36 equities making new 52-week lows in Tuesday’s session. Puma Biotechnology Inc. (NYSE: PBYI) posted a new 52-week...
Published:
Last Updated:
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
Published:
Last Updated:
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
Published:
Last Updated:
24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added some color.
Published:
Last Updated:
These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks, even if many of these are large cap stocks.
Published:
Last Updated:
Monday’s top analyst upgrades, downgrades and initiations includes Coach, DuPont, GoPro, Match, Puma Biotechnology, Square and Tesla Motors.
Published:
Last Updated:
The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the course of the past week.
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations include Amazon.com, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie & Fitch.
Published:
Credit Suisse expects that biotech stocks will see the most promotions in the coming rebalance of the Russell Indexes.
Published:
Here is a look at the top performers for 2014, nine stocks that have doubled and have a current market cap of at least $5 billion.
Published:
Last Updated:
Puma Biotechnology has just defied all odds in biotech. The stock has risen more than 200% in a single day, and its market cap magically jumped from close to $1.7 billion to almost $7 billion.
Published:
Last Updated:
ThinkstockBinary events are often the key element in moving a biotech or health care stock higher. Negative binary results or actions often can move shares drastically lower. We scan our 24/7 Wall...
Published:
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of stocks that are rated...
Published:
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Could one of these biotech takeover candidates be the next target?
Published: